Freeline Therapeutics Holdings plc FRLN
$ 6.48
0.0%
Annual report 2022
added 12-21-2024
Country |
Britain |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Theresa Marie Heggie |
Employees in the company |
200 |
Shares |
59.3 M |
Market Cap[1] |
$ 384 M |
EBITDA (LTM) |
$ -81.7 M |
P/E (LTM) |
-0.14 |
P/S (LTM) |
- |
EPS (LTM) |
-3.46 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.